Andere talen Carmell Corporation

Aandelen

CTCX

US1429221039

Beurs gesloten - Nasdaq Andere beurzen 22:30:00 07-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,56 ^USD	-1,16%		+2,81%	-32,81%

15/05	Carmell Corporation rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
01/04	Carmell Corporation meldt resultaten voor het op 31 december 2023 afgesloten boekjaar	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Carmell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Carmell Announces Successful Closing of $3.0 Million Private Placement	11/04
Carmell Corporation announced that it has received $3 million in funding	11/04
Carmell Announces $3.0 Million Private Placement	04/04
Carmell Corporation announced that it expects to receive $3 million in funding	04/04
Carmell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction	27/03
An undisclosed buyer completed the acquisition of Axolotl Biologix, Inc. from Carmell Corporation.	26/03
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Fed Maintains Rate Cut Outlook	21/03
Carmell Sells Axolotl Biologix Unit -- Shares Jump Premarket	21/03
An undisclosed buyer entered into a a definitive agreement to acquire Axolotl Biologix, Inc. from Carmell Corporation ).	20/03
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024	26/02
Carmell Corporation Announces Appointment of Dr. Bradley Calobrace to Scientific Advisory Board	17/01
Carmell Corp Announces Appointment of Dr. Jason D. Bloom to Scientific Advisory Board	17/01
Carmell Corporation Announces Appointment of Dr. Adam Rubinstein to Scientific Advisory Board	17/01
Carmell Corporation Announces Appointment of Dr. Gregory A. Buford to Scientific Advisory Board	17/01
Carmell Corporation Announces Appointment of Dr. Sean Kelishadi to Scientific Advisory Board	17/01
Carmell Corporation Announces Addition of Two Independent Directors	16/11
Carmell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Carmell Therapeutics Corporation(NasdaqCM:CTCX) added to S&P TMI Index	18-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Carmell Corporation

Aandelen

CTCX

US1429221039

Andere talen

Filters